BioSig Technologies, Inc. STEX Warrants and Rights Outstanding
Warrants and Rights Outstanding at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ClassOfWarrantOrRightOutstanding.
The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s warrants and rights outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s warrants and rights outstanding?
- BioSig Technologies, Inc. (STEX) reported warrants and rights outstanding of 1.6M in Q1 2026.
- How has BioSig Technologies, Inc.'s warrants and rights outstanding changed year-over-year?
- BioSig Technologies, Inc.'s warrants and rights outstanding decreased by 70.5% year-over-year, from 5.6M to 1.6M.
- What is the long-term trend for BioSig Technologies, Inc.'s warrants and rights outstanding?
- Over 5 years (2020 to 2025), BioSig Technologies, Inc.'s warrants and rights outstanding has grown at a 3.7% compound annual growth rate (CAGR), from 1.4M to 1.7M.
- What does warrants and rights outstanding mean?
- This represents the total number or value of derivative instruments issued by the company that grant holders the right to purchase common stock at a predetermined price. It is a critical metric for assessing potential future dilution of existing shareholders' equity.